Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Perimenopause and Mental Health: Why Mood Shifts and What Helps

Clinically reviewed by Elizabeth Lokenauth, PA-C, CAQ-Psy

Reviewed October 19, 2026 · Last updated October 9, 2026

Key Takeaways

  • Perimenopause raises the risk of depression. A 2024 meta-analysis found 40% higher odds compared with premenopause, and women with no prior depression were twice as likely to develop significant symptoms.
  • Anxiety can show up for the first time, too. Women with low anxiety before the transition were more likely to report high anxiety during and after it.
  • Antidepressants and psychotherapy are front-line treatments. Estradiol isn't approved for depression, but trials show antidepressant effects in perimenopausal women.
  • A past episode of depression is one of the strongest risk factors, so tell your clinician about your history early.

“I feel like some doctors do not take me seriously.” It’s a common feeling in midlife, when new anxiety or a low mood gets written off as stress, a busy season, or just getting older. The biology says otherwise. The Menopause Society notes that estrogen receptors are spread throughout the brain, including regions that regulate mood. During perimenopause, federal women’s health guidance explains that hormone levels change randomly as the ovaries wind down. A brain tuned with real precision to a monthly rhythm is suddenly working with signals that rise and fall without warning.

Clinicians have a clear standard for what to do about it. A 2018 expert guideline on perimenopausal depression, written by an expert panel after a systematic review of the published literature, names antidepressants and psychotherapy as front-line treatments, and it describes evidence that estrogen has antidepressant effects in perimenopausal women. The results are real, and the science is well established.

But a guideline only helps if someone connects your mood to the transition you’re in, and at Siggy we’d rather start with your whole story than with a single symptom.

This guide covers how much perimenopause raises the risk of depression and anxiety, why it happens, who is most vulnerable, and which treatments have evidence behind them. Perimenopausal mood changes reflect a sensitive brain meeting an unpredictable hormonal shift, and that framing comes straight from the research.

What This Page Covers

Can Perimenopause Cause Depression and Anxiety?

Yes, and the evidence comes from studies that followed women for years. In the SWAN depression study, which tracked 221 women through the transition with yearly structured clinical interviews, women were two to four times more likely to have a major depressive episode during perimenopause or early postmenopause than before it. That held even after accounting for past depression, life events, and hormone levels.

A 2024 meta-analysis of prospective studies pooled data from 9,141 women and found 40% higher odds of depressive symptoms or diagnoses in perimenopause compared with premenopause. It found no significant increase after menopause.

This isn’t only about women with a history of depression. In a Harvard cohort study of 460 women, those with no lifetime history of major depression who entered perimenopause were twice as likely to develop significant depressive symptoms as women of the same age who hadn’t.

Anxiety follows a similar pattern. A SWAN anxiety analysis of 2,956 women found that those with low anxiety before the transition had 56% to 61% higher odds of high anxiety during perimenopause or after menopause. Women who were already highly anxious stayed that way, without a further rise tied to menopause stage. If anxiety feels new in your 40s, that finding may sound familiar.

Why Does Perimenopause Affect Your Mood?

The most supported explanation is change, rather than a simple drop in hormones. The Menopause Society describes a “window of vulnerability,” in which some women are more sensitive to hormone shifts, while noting that the precise mechanism isn’t known. In SWAN, single yearly hormone levels did not predict who became depressed, which is consistent with the idea that unpredictable swings and individual sensitivity matter more than any one number.

Timing seems to matter, too. In a randomized prevention trial of 172 women without depression, 12 months of transdermal estradiol plus intermittent micronized progesterone cut the share who developed clinically significant depressive symptoms from 32.3% on placebo to 17.3%. The benefit showed up in the early transition, but not in the late transition or after menopause.

Physical symptoms pile on. The 2018 guideline notes that hot flashes, night sweats, and broken sleep often overlap with depression and can make it harder to recognize. Life adds weight too: the ACOG article linked below points out that many people in their 40s and 50s are juggling demanding jobs, children, and aging parents at once. Our guide to hormonal depression explains how hormone shifts affect mood across life stages.

Who Is Most at Risk?

A past episode of depression is one of the clearest signals. The 2018 guideline reports that most women who have a major depressive episode during perimenopause have had one before, and SWAN found that a history of major depression strongly predicted depression throughout the study.

Other patterns raise the odds:

  • Hot flashes and night sweats, which were linked to somewhat greater depression risk in the Harvard study
  • Recent stressful life events, which strengthened the mood benefit of estradiol in the prevention trial above, a sign that stress and hormonal change may interact

If any of these describe you, it’s worth raising early, before symptoms build.

How Do You Know It’s Perimenopause?

Perimenopause usually starts in the mid- to late 40s and lasts about four years on average, though it can run from two to eight, according to the federal guidance above. Irregular periods are often the first clue.

A blood test usually won’t settle it. The same guidance explains that hormone levels go up and down unpredictably during the transition, so providers don’t usually recommend testing without a specific medical reason. Clinicians look at the whole pattern instead: your age, cycle changes, physical symptoms, and mood history.

Mood changes can look like premenstrual symptoms that no longer follow your cycle. An ACOG patient article by an ob-gyn who is also a psychiatrist says about 4 in 10 women have PMS-like mood symptoms during perimenopause, such as irritability, low energy, tearfulness, or trouble concentrating. Unlike PMS, these symptoms may not follow your cycle at all. If premenstrual mood changes have hit you hard in the past, our post on PMDD covers that pattern.

The Menopause Society advises seeing a clinician when depression symptoms last most of the day, nearly every day, for at least two weeks. It’s also time to get help when anxiety or irritability sticks around or gets in the way of work, sleep, or relationships. Our guide to signs of depression in women can help you put words to what you’re feeling.

Which Treatments Help Perimenopausal Mood Symptoms?

You have more than one evidence-based option, and they can be combined. Here’s how the main options compare, based on the 2018 guideline and the estradiol trials linked in this section.

Option Guideline Role Best Studied For
Antidepressants Front-line Clinical depression in perimenopause
Psychotherapy Front-line Clinical depression in perimenopause
Transdermal estradiol Not approved for depression Perimenopausal depression, especially with hot flashes

Antidepressants

Antidepressants are the standard medication approach, and some SSRIs can ease hot flashes too. In a hot flash trial of 205 menopausal women, escitalopram reduced hot flash frequency and severity compared with placebo. The authors called it an effective nonhormonal option, though that use is off-label. Our guide to the first eight weeks on an antidepressant covers what to expect early on.

Hormone Therapy

Estrogen has meaningful evidence for mood during perimenopause. In a 12-week estradiol trial of 50 perimenopausal women with depression, 68% on a transdermal estradiol patch reached remission, compared with 20% on placebo. The trial was small, and the guideline describes data on estrogen plus progestin as sparse and inconclusive.

Safety labeling has also changed. In November 2025, an FDA announcement said the agency would remove boxed warnings about heart disease, breast cancer, and probable dementia from menopause hormone therapy labels. The boxed warning for endometrial cancer stays on estrogen-alone products, and the FDA’s labeled recommendation is to start systemic therapy within 10 years of menopause onset or before age 60. Hormone therapy is still a medical decision that depends on your history, and it is not FDA-approved to treat depression. It’s often managed by a gynecologist or primary care clinician, so coordinating with whoever treats your mood matters.

What Can You Do Day to Day?

Treatment works better with a few steady habits behind it.

  • Protect sleep. The ACOG article above recommends a consistent sleep schedule, no screens in the hour before bed, and a cool, dark bedroom. Our post on sleep hygiene and mental health has more.
  • Track your cycle, hot flashes, sleep, and mood together for a few months. That record helps your clinician see whether mood shifts follow the physical changes.
  • Name your history. Tell any new clinician about past depression, postpartum mood changes, or premenstrual mood symptoms.
  • Lower the load where you can. The ACOG article notes that anything that reduces stress can help, such as meditation, yoga, or journaling.

If you’re having thoughts of suicide or self-harm, call or text 988 now. In an emergency, call 911.

This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Bring Your Whole Midlife Story to One Place

Perimenopausal mood changes are common, measurable, and treatable, and the hardest part is often getting someone to connect the dots between your sleep, your cycle, and how you feel. Start your anonymous intake with Siggy to describe what’s been happening, in your own words and at your pace. It’s free, asks for no name or email, and gives you a downloadable summary you can share with your gynecologist, primary care clinician, or anyone else on your care team. If treatment for depression or anxiety makes sense, a licensed prescriber reviews your full clinical picture before anything is prescribed. Hormone therapy decisions stay with the clinician who manages your menopause care, and your summary helps everyone start from the same page.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

Can perimenopause cause depression?

Yes, perimenopause can raise the risk of depression. In the Study of Women's Health Across the Nation, women were two to four times more likely to have a major depressive episode during perimenopause or early postmenopause than before. A 2024 meta-analysis found 40% higher odds of depressive symptoms or diagnoses in perimenopause compared with premenopause. Depression is treatable at this stage, often with antidepressants, psychotherapy, or both.

Can perimenopause cause anxiety even if I've never had it before?

Yes. In a 10-year analysis of nearly 3,000 midlife women, those with low anxiety before the transition were more likely to report high anxiety during perimenopause and after menopause, independent of hot flashes and life stress. Women who were already highly anxious stayed anxious but didn't show a further rise tied to menopause stage.

How do I know if my mood changes are from perimenopause?

There isn't a single test. Perimenopause usually starts in the mid- to late 40s, often with irregular periods, hot flashes, or sleep changes. Hormone blood tests usually can't confirm it because levels rise and fall unpredictably. Clinicians look at your age, cycle changes, physical symptoms, and mood history together, so tracking your periods and symptoms for a few months is one of the most useful things you can bring to an appointment.

Does hormone therapy help perimenopausal depression?

Hormone therapy may help some women, but it isn't approved to treat depression. In a 12-week trial of 50 perimenopausal women with depression, 68% on transdermal estradiol reached remission compared with 20% on placebo. A 2018 expert guideline says estrogen has antidepressant effects in perimenopausal women, especially those with hot flashes, while antidepressants and psychotherapy remain front-line treatments.

Can antidepressants help with hot flashes too?

Some can. In a randomized trial of 205 menopausal women, escitalopram reduced hot flash frequency and severity compared with placebo, and the authors described it as an effective nonhormonal, off-label option. Escitalopram isn't FDA-approved for hot flashes, so that use is off-label and the decision should be made with your prescriber.

How long do perimenopause mood symptoms last?

There's no fixed timeline, but perimenopause itself usually lasts about four years and can range from two to eight. In long-term studies, depression risk was highest during perimenopause and the first years after the final period. Symptoms that last more than two weeks or affect your daily life are worth treating rather than waiting out.

Sources

  1. The Menopause Society. Mental Health. menopause.org
  2. Office on Women’s Health, U.S. Department of Health and Human Services. Menopause basics. Updated April 2026. womenshealth.gov
  3. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Journal of Women’s Health. 2019;28(2):117-134. doi:10.1089/jwh.2018.27099.mensocrec
  4. Bromberger JT, Kravitz HM, Chang YF, et al. Major depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN). Psychological Medicine. 2011;41(9):1879-1888. doi:10.1017/S003329171100016X
  5. Badawy Y, Spector A, Li Z, Desai R. The risk of depression in the menopausal stages: a systematic review and meta-analysis. Journal of Affective Disorders. 2024;357:126-133. doi:10.1016/j.jad.2024.04.041
  6. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard Study of Moods and Cycles. Archives of General Psychiatry. 2006;63(4):385-390. doi:10.1001/archpsyc.63.4.385
  7. Bromberger JT, Kravitz HM, Chang Y, et al. Does risk for anxiety increase during the menopausal transition? Study of Women’s Health Across the Nation. Menopause. 2013;20(5):488-495. doi:10.1097/GME.0b013e3182730599
  8. Gordon JL, Rubinow DR, Eisenlohr-Moul TA, et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry. 2018;75(2):149-157. doi:10.1001/jamapsychiatry.2017.3998
  9. Silver NE. Mood Changes During Perimenopause Are Real. Here’s What to Know. American College of Obstetricians and Gynecologists. 2023. acog.org
  10. Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011;305(3):267-274. doi:10.1001/jama.2010.2016
  11. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Archives of General Psychiatry. 2001;58(6):529-534. doi:10.1001/archpsyc.58.6.529
  12. U.S. Food and Drug Administration. HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. November 10, 2025. fda.gov